{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:34:52Z","timestamp":1792697692946,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10787-025-01683-4","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T06:51:22Z","timestamp":1741157482000},"page":"1899-1905","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic efficacy of zoledronic acid combined with calcium and calcitriol in the treatment of senile osteoporosis in elderly patients"],"prefix":"10.1007","volume":"33","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5309-1131","authenticated-orcid":false,"given":"Xiaojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"1683_CR1","doi-asserted-by":"crossref","unstructured":"Arceo-Mendoza RM, Camacho PM (2021) Osteoporosis: latest guidelines. Updates on osteoporosis, an issue of endocrinology and metabolism clinics of North America, E-BookUpdates on Osteoporosis, An Issue of Endocrinology and Metabolism Clinics of North America, E-Book: Updates on Osteoporosis, An Issue of Endocrinology and Metabolism Clinics of North America, E-BookUpdates on Osteoporosis, An Issue of Endocrinology and Metabolism Clinics of North America, E-Book, 50(2):167","DOI":"10.1016\/j.ecl.2021.03.009"},{"issue":"3","key":"1683_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3803\/EnM.2021.301","volume":"36","author":"JP Brown","year":"2021","unstructured":"Brown JP (2021) Long-term treatment of postmenopausal osteoporosis. Endocrinol Metab 36(3):544\u2013552","journal-title":"Endocrinol Metab"},{"issue":"1","key":"1683_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5414\/CN110705","volume":"98","author":"P-J Chi","year":"2022","unstructured":"Chi P-J, Shih-Yuan H, Hsiao F-T, Liou H-H, Tsai J-P (2022) Serum osteocalcin concentration as an independent biomarker of osteoporosis in patients with chronic kidney disease. Clin Nephrol 98(1):1","journal-title":"Clin Nephrol"},{"issue":"5","key":"1683_CR4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00198-023-07005-0","volume":"35","author":"YW Choo","year":"2024","unstructured":"Choo YW, Mohd Tahir NA, Mohamed Said MS, Makmor Bakry M (2024) Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41. Osteoporos Int 35(5):745\u2013757","journal-title":"Osteoporos Int"},{"issue":"4","key":"1683_CR5","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/biom11040506","volume":"11","author":"\u017b Ciosek","year":"2021","unstructured":"Ciosek \u017b, Kot K, Kosik-Bogacka D, \u0141anocha-Arendarczyk N, Rotter I (2021) The effects of calcium, magnesium, phosphorus, fluoride, and lead on bone tissue. Biomolecules 11(4):506","journal-title":"Biomolecules"},{"issue":"9","key":"1683_CR6","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00198-023-06811-w","volume":"34","author":"LE Crack","year":"2023","unstructured":"Crack LE, Haider IT, Simonian N, Barroso J, Gabel L, Schnitzer TJ, Edwards WB (2023) Zoledronic acid after spinal cord injury mitigates losses in proximal femoral strength independent of ambulation ability. Osteoporos Int 34(9):1637\u20131645","journal-title":"Osteoporos Int"},{"issue":"1","key":"1683_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jbmr.3217","volume":"33","author":"BR Gillies","year":"2018","unstructured":"Gillies BR, Ryan BA, Tonkin BA, Poulton IJ, Ma Y, Kirby BJ, Kovacs CS (2018) Absence of calcitriol causes increased lactational bone loss and lower Milk calcium but does not impair post-lactation bone recovery in Cyp27b1 null mice. J Bone Miner Res 33(1):16\u201326","journal-title":"J Bone Miner Res"},{"key":"1683_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068033","author":"MN H\u00e4ndel","year":"2023","unstructured":"H\u00e4ndel MN, Cardoso I, Von B\u00fclow C, Rohde JF, Ussing A, Nielsen SM, Diez-Perez A (2023) Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials. BMJ. https:\/\/doi.org\/10.1136\/bmj-2021-068033","journal-title":"BMJ"},{"key":"1683_CR9","doi-asserted-by":"publisher","first-page":"812385","DOI":"10.3389\/fendo.2021.812385","volume":"12","author":"Y Herrera-Mart\u00ednez","year":"2022","unstructured":"Herrera-Mart\u00ednez Y, Contreras Gonz\u00e1lez MJ, Pedraza-Ar\u00e9valo S, Guerrero Mart\u00ednez MDC, Rodrigo Mart\u00ednez \u00c1, Gonz\u00e1lez Menchen A, Luque RM (2022) Calcitriol-mediated hypercalcemia, somatostatin receptors expression and 25-hydroxyvitamin D3\u20131\u03b1-hydroxylase in GIST tumors. Front Endocrinol 12:812385","journal-title":"Front Endocrinol"},{"issue":"1","key":"1683_CR10","first-page":"6053410","volume":"2022","author":"Q Hu","year":"2022","unstructured":"Hu Q, Wang Q, Liu F, Yao L, Zhang L, Chen G (2022) Combination of calcitriol and zoledronic acid on PINP and \u03b2-CTX in postoperative patients with diabetic osteoporosis: a randomized controlled trial. Dis Mark 2022(1):6053410","journal-title":"Dis Mark"},{"issue":"1","key":"1683_CR11","doi-asserted-by":"publisher","first-page":"2711938","DOI":"10.1155\/2022\/2711938","volume":"2022","author":"W Jing","year":"2022","unstructured":"Jing W, Dai Y, Zhu J, Deng S (2022) [Retracted] Clinical efficacy and safety evaluation of calcitriol combined with bisphosphonates in the therapy of postmenopausal osteoporosis: based on a retrospective cohort study. BioMed Res Int 2022(1):2711938","journal-title":"BioMed Res Int"},{"issue":"5","key":"1683_CR12","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.mcna.2020.06.004","volume":"104","author":"CB Johnston","year":"2020","unstructured":"Johnston CB, Dagar M (2020) Osteoporosis in older adults. Med Clin N Am 104(5):873\u2013884","journal-title":"Med Clin N Am"},{"key":"1683_CR13","doi-asserted-by":"publisher","DOI":"10.1530\/JME-22-0108","author":"P Kar","year":"2023","unstructured":"Kar P, Goswami R (2023) Effect of calcitriol and calcium on basal ganglia calcification in hypoparathyroidism: experimental models. J Mol Endocrinol. https:\/\/doi.org\/10.1530\/JME-22-0108","journal-title":"J Mol Endocrinol"},{"issue":"3","key":"1683_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00198-022-06642-1","volume":"34","author":"M Kashii","year":"2023","unstructured":"Kashii M, Kamatani T, Nagayama Y, Miyama A, Tsuboi H, Ebina K (2023) Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis. Osteoporos Int 34(3):563\u2013572","journal-title":"Osteoporos Int"},{"key":"1683_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11657-019-0647-5","volume":"14","author":"Y-K Lee","year":"2019","unstructured":"Lee Y-K, Kim H-J, Park JW, Won S, Hwang J-S, Ha Y-C, Koo K-H (2019) Transcultural adaptation and psychometric properties of the Korean version of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41). Arch Osteoporos 14:1\u20137","journal-title":"Arch Osteoporos"},{"key":"1683_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12871-018-0543-3","volume":"18","author":"R Li","year":"2018","unstructured":"Li R, Liu H, Dilger JP, Lin J (2018) Effect of propofol on breast cancer cell, the immune system, and patient outcome. BMC Anesthesiol 18:1\u20138","journal-title":"BMC Anesthesiol"},{"issue":"4","key":"1683_CR17","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3892\/etm.2017.4128","volume":"13","author":"H Liu","year":"2017","unstructured":"Liu H, Xiong Y, Zhu X, Gao H, Yin S, Wang J, Wang P (2017) Icariin improves osteoporosis, inhibits the expression of PPAR\u03b3, C\/EBP\u03b1, FABP4 mRNA, N1ICD and jagged1 proteins, and increases Notch2 mRNA in ovariectomized rats. Exp Therap Med 13(4):1360\u20131368","journal-title":"Exp Therap Med"},{"issue":"12","key":"1683_CR18","doi-asserted-by":"publisher","first-page":"10817","DOI":"10.1039\/D0FO00787K","volume":"11","author":"C Liu","year":"2020","unstructured":"Liu C, Kuang X, Li K, Guo X, Deng Q, Li D (2020) Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. Food Funct 11(12):10817\u201310827","journal-title":"Food Funct"},{"issue":"1","key":"1683_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/jcpt.13056","volume":"45","author":"L Lu","year":"2020","unstructured":"Lu L, Lu L, Zhang J, Li J (2020) Potential risks of rare serious adverse effects related to long-term use of bisphosphonates: an overview of systematic reviews. J Clin Pharm Therap 45(1):45\u201351","journal-title":"J Clin Pharm Therap"},{"issue":"8","key":"1683_CR20","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/jbmr.4563","volume":"37","author":"PD Miller","year":"2020","unstructured":"Miller PD, Adachi JD, Albergaria BH, Cheung AM, Chines AA, Gielen E, Reid IR (2020) Efficacy and safety of romosozumab among postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease. J Bone Miner Res 37(8):1437\u20131445","journal-title":"J Bone Miner Res"},{"issue":"11","key":"1683_CR21","volume":"4","author":"AM M\u00f8ller","year":"2020","unstructured":"M\u00f8ller AM, Delaisse JM, Olesen JB, Bechmann T, Madsen JS, S\u00f8e K (2020) Zoledronic acid is not equally potent on osteoclasts generated from different individuals. J Bone Miner Res plus 4(11):e10412","journal-title":"J Bone Miner Res plus"},{"issue":"1","key":"1683_CR22","doi-asserted-by":"publisher","first-page":"3670007","DOI":"10.1155\/2022\/3670007","volume":"2022","author":"H Ni","year":"2022","unstructured":"Ni H, Zhang S, Niu X, Dai S (2022) Meta-analysis of effects of nutritional intervention combined with calcium carbonate D3 tablets on bone mineral density, bone metabolism, and curative effect in patients with osteoporosis. Contrast Media Mol Imaging 2022(1):3670007","journal-title":"Contrast Media Mol Imaging"},{"issue":"2","key":"1683_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/M22-1034","volume":"176","author":"A Qaseem","year":"2023","unstructured":"Qaseem A, Hicks LA, Etxeandia-Ikobaltzeta I, Shamliyan T, Cooney TG, Physicians CGC (2023) Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians. Ann Internal Med 176(2):224\u2013238","journal-title":"Ann Internal Med"},{"issue":"3","key":"1683_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00223-022-01039-y","volume":"112","author":"JA Riancho","year":"2023","unstructured":"Riancho JA (2023) Diagnostic approach to patients with low serum alkaline phosphatase. Calcif Tissue Int 112(3):289\u2013296","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"1683_CR25","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.3390\/ijms22042105","volume":"22","author":"G Rinonapoli","year":"2021","unstructured":"Rinonapoli G, Ruggiero C, Meccariello L, Bisaccia M, Ceccarini P, Caraffa A (2021) Osteoporosis in men: a review of an underestimated bone condition. Int J Mol Sci 22(4):2105","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1683_CR26","volume":"15","author":"H Rouco","year":"2023","unstructured":"Rouco H, Garc\u00eda-Garc\u00eda P, Briffault E, Diaz-Rodriguez P (2023) Modulating osteoclasts with nanoparticles: a path for osteoporosis management? Wiley Interdiscip Rev: Nanomed Nanobiotechnol 15(4):e1885","journal-title":"Wiley Interdiscip Rev: Nanomed Nanobiotechnol"},{"key":"1683_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.899469","volume":"13","author":"L Tanner","year":"2022","unstructured":"Tanner L, Bergwik J, Single AB, Bhongir RK, Erjef\u00e4lt JS, Egesten A (2022) Zoledronic acid targeting of the mevalonate pathway causes reduced cell recruitment and attenuates pulmonary fibrosis. Front Pharmacol 13:899469","journal-title":"Front Pharmacol"},{"key":"1683_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s00223-021-00930-4","volume":"112","author":"SD Vasikaran","year":"2023","unstructured":"Vasikaran SD, Miura M, Pikner R, Bhattoa HP, Cavalier E, IOF-IFCC Joint Committee on Bone Metabolism (C-BM) (2023) Practical considerations for the clinical application of bone turnover markers in osteoporosis. Calcif Tissue Int 112:148\u2013157","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1683_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.5114\/reum.2022.119041","volume":"60","author":"T Widiyanto","year":"2022","unstructured":"Widiyanto T, Hidayat R, Wibowo RSAK, Shatri H (2022) Correlation between anti-mutated citrullinated vimentin and bone turnover markers (CTX-1 and P1NP) in patients with rheumatoid arthritis in remission and low-disease activity. Reumatologia\/rheumatology 60(1):252\u2013257","journal-title":"Reumatologia\/rheumatology"},{"issue":"1","key":"1683_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2334\/josnusd.19-0130","volume":"62","author":"S Zafar","year":"2020","unstructured":"Zafar S, Cullinan MP, Drummond BK, Seymour GJ, Coates DE (2020) Effects of zoledronic acid and geranylgeraniol on angiogenic gene expression in primary human osteoclasts. J Oral Sci 62(1):79\u201383","journal-title":"J Oral Sci"},{"issue":"8","key":"1683_CR31","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1007\/s10238-023-01197-9","volume":"23","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Yin L, Lai Q, Zhao Y, Peng H (2023) Advances in the pathogenesis and therapeutic strategies of angioimmunoblastic T-cell lymphoma. Clin Exp Med 23(8):4219\u20134235","journal-title":"Clin Exp Med"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01683-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01683-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01683-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:01:49Z","timestamp":1744416109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01683-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1683"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01683-4","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local ethics committee of the 907 Hospital of the Chinese People\u2019s Liberation Army Joint Logistic Support Force, all experiments were performed in accordance with relevant guidelines and regulations such as the Declaration of Helsinki and the patients signed the informed consent form and agreed to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}